These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position. McNicol GP Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840 [No Abstract] [Full Text] [Related]
16. [Effect of heparin, acetylsalicylic acid and sulfinpyrazone on thrombocyte morphology]. Fritsche HM; Ketterl R; Leimgruber D; Blümel G Med Welt; 1979 Mar; 30(10):365-9. PubMed ID: 763120 [No Abstract] [Full Text] [Related]
17. Antiplatelet agents in prevention of myocardial infarction. Kshirsagar NA Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947 [No Abstract] [Full Text] [Related]
18. Actions and clinical status of platelet-suppressive agents. Didisheim P; Fuster V Semin Hematol; 1978 Jan; 15(1):55-72. PubMed ID: 341328 [No Abstract] [Full Text] [Related]
19. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview. Weiss HJ Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351 [TBL] [Abstract][Full Text] [Related]
20. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related] [Next] [New Search]